Citation: Ts. Lamberg et al., Lack of effect of terfenadine on the pharmacokinetics of the CYP3A4 substrate buspirone, PHARM TOX, 84(4), 1999, pp. 165-169
Citation: Kt. Kivisto et al., Interactions of buspirone with itraconazole and rifampicin: Effects on thepharmacokinetics of the active 1-(2-pyrimidinyl)-piperazine metabolite of buspirone, PHARM TOX, 84(2), 1999, pp. 94-97
Citation: Ts. Lamberg et al., The effect of fluvoxamine on the pharmacokinetics and pharmacodynamics of buspirone, EUR J CL PH, 54(9-10), 1998, pp. 761-766